Sponsor:
Baylor College of Medicine
Code:
NCT06176690
Conditions
CD30-Positive Diffuse Large B-Cell Lymphoma
Anaplastic Large Cell Lymphoma, T Cell and Null Cell Type
Anaplastic Large Cell Lymphoma, ALK-Positive
Peripheral T-cell Lymphoma
Anaplastic Large Cell Lymphoma, ALK-negative
Eligibility Criteria
Sex: All
Age: 12 - 70+
Healthy Volunteers: Not accepted
Interventions
C7R.CD30.CAR-EBVST cells
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-01-09. This information was provided to ClinicalTrials.gov by Baylor College of Medicine on 2025-11-13.